RESEARCH · GHK-CU · COMPROMISED WOUND MODELS
GHK-Cu in Compromised Wound Models: Ischaemic, Irradiated, Diabetic and Infected Wounds and the Carriers Built Around It
PurixLab’s GHK-Cu 50mg is a research vial of the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine. Our earlier articles cover a research overview, skin permeation and formulation, gene expression and matrix remodelling and bone and tissue-engineering scaffolds, and our dermal wound model comparison looks at standard wounds. This article looks at the harder models: wounds made ischaemic, irradiated, diabetic or infected, and the carriers researchers have built around the complex. These are findings from published research; the vial is supplied for laboratory research use only, and nothing here is treatment guidance or a claim about any PurixLab product.
Why compromised-healing models are a separate test
Small, clean wounds in healthy rodents close on their own, which leaves little room to show an effect. Researchers therefore impair healing on purpose: by cutting off part of the blood supply, irradiating the skin weeks beforehand, inducing diabetes or seeding the wound with bacteria. Each model stresses a different part of repair, and results in one do not carry over automatically to another.
Ischaemic and irradiated skin: results point both ways
- Ischaemic flaps in rats. In twenty-four rats with full-thickness wounds inside an ischaemic skin flap, a topical tripeptide-copper gel reduced wound area by 64.5% at day 13, against 45.6% with the gel vehicle and 28.2% without treatment, and treated wounds had lower TNF-alpha and matrix metalloproteinase 2 and 9 levels [1].
- Irradiated flaps in rats. A later study irradiated the rats’ backs, waited 28 days and then raised skin flaps. With 13 treated and 10 control animals, the mean ischaemic area was 5.0 square centimetres with GHK-Cu gel and 3.8 with the control ointment (P = .011, above the study’s P < .01 threshold), and vessel counts and VEGF staining did not differ. The authors concluded that there was no difference from controls [2].
- Diabetic laparotomy in mice. When copper peptide, ascorbic acid, stanozolol or TGF-β were each applied once in a hydrogel to abdominal wall incisions in diabetic mice, only ascorbic acid improved skin breaking strength at 14 days [3].
So the two negative studies sit alongside the positive ischaemic-wound result, and the models differ in species, wound type and how often the material was applied.
Diabetic wounds: the peptide inside a carrier
Most diabetic-wound studies do not test GHK-Cu on its own. They build it into a matrix:
- Collagen films. In diabetic rats, collagen carrying a biotinylated GHK derivative increased the rate of wound contraction and raised skin glutathione and ascorbic acid levels compared with untreated and collagen-only groups [4]. The peptide here was modified and not copper-loaded.
- Self-assembling nanofibres. A RADA16 peptide scaffold functionalised with GHK to chelate copper sped wound closure and collagen deposition in healthy and diabetic mice, with higher eNOS and CD31 staining [5].
- Lipidated nanofibres in hyaluronic acid. A lipid-tailed GHK formed nanofibres inside a light-crosslinked hyaluronic acid gel; adding copper gave better healing than non-lipidated GHK, at a level comparable to the growth factor EGF in that study [6].
- A dimeric copper peptide. A two-unit copper peptide was more stable against proteases than the monomer and, in a ROS-responsive hydrogel, achieved 97.2% closure of infected wounds [7].
Two 2026 studies use the copper differently. Glucose oxidase in the gel consumes excess glucose and produces hydrogen peroxide, and the copper in GHK-Cu then breaks the peroxide down to oxygen in a catalase-like step, easing hypoxia [8,9]. Here the complex acts partly as a catalyst, not only as a signalling peptide.
Infected wounds and metal nanoparticles
- Silver nanoparticles. GHK- and GHK-Cu-capped silver nanoparticles of 45.92 and 56.82 nm inhibited S. aureus and E. coli at 8 micrograms per millilitre and improved healing of S. aureus-infected wounds, but their IC50 values in L929 fibroblasts were 6.75 to 6.99 in the same units [10]. The concentrations that inhibit bacteria and harm cells were close.
- Silver conjugates in a scratch assay. A copper tripeptide-silver conjugate gave 62.37% closure, 2.82-fold better than the free peptide, against 29.53% for peptide-free silver particles [11].
- Food-derived and gold carriers. An egg-white and konjac hydrogel loaded with GHK-Cu was reported to be antibacterial, anti-inflammatory and haemostatic in infected wounds [12]. GHK nanofibres holding gold particles of about 3 nm combined a wound-healing effect with photothermal killing of cancer cells, and swapping the sequence to KHG changed lysine exposure and performance [13].
- Radiation skin injury. A chitosan and hyaluronic acid gel with GHK-Cu attached by Schiff-base links and antioxidant carbon dots accelerated healing of radiation-induced skin injury in vivo [14].
Reading this literature critically
- Composite materials. In most carrier studies GHK-Cu is one active part among several, such as silver, glucose oxidase, carbon dots or a ROS-scavenging gel, so the effect of the peptide alone cannot be separated [7,8,14,10].
- Specificity. Copper complexes of unrelated tripeptides, such as Cu-AAA and Cu-VYV, also promoted cell migration in scratch assays [15], so not every effect may be specific to the GHK sequence.
- Negative results. The irradiated-flap and diabetic-incision studies found no benefit [2,3], a reminder that positive carrier studies are only part of the record.
- Small animal models. All of the in vivo data come from rodents, with short follow-up.
What remains open
- How free GHK-Cu compares with each carrier in the same compromised-healing model.
- How much of the effect comes from copper chemistry and how much from the peptide.
- Whether the margin between antibacterial and cytotoxic concentrations allows safe use of metal-nanoparticle hybrids.
GHK-Cu 50mg at PurixLab
GHK-Cu 50mg: a labelled lyophilized research vial with 50mg per vial, C$49 per vial (CAD, before tax), supplied for laboratory research only. It is not a cosmetic; our separate Copper Facial Mask is the finished cosmetic product. Batch documentation is available on request. Product page: purixlab.com/product/ghk-cu-50mg/.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Canapp SO, Farese JP, Schultz GS, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. PubMed 14648529 · doi:10.1111/j.1532-950x.2003.00515.x
- Parker NP, Ardeshirpour F, Schmechel SC, et al. Effects of topical copper tripeptide complex on wound healing in an irradiated rat model. Otolaryngol Head Neck Surg. 2013;149(3):384-9. PubMed 23744835 · doi:10.1177/0194599813492644
- Konerding MA, Ziebart T, Wolloscheck T, et al. Impact of single-dose application of TGF-β, copper peptide, stanozolol and ascorbic acid in hydrogel on midline laparatomy wound healing in a diabetic mouse model. Int J Mol Med. 2012;30(2):271-6. PubMed 22614259 · doi:10.3892/ijmm.2012.1005
- Arul V, Kartha R, Jayakumar R. A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sci. 2007;80(4):275-84. PubMed 17049946 · doi:10.1016/j.lfs.2006.09.018
- Yang X, Zhang Y, Huang C, et al. Biomimetic Hydrogel Scaffolds with Copper Peptide-Functionalized RADA16 Nanofiber Improve Wound Healing in Diabetes. Macromol Biosci. 2022;22(8):e2200019. PubMed 35598070 · doi:10.1002/mabi.202200019
- Lee S, Lee SM, Lee SH, et al. In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing. Acta Biomater. 2023;172:159-174. PubMed 37832839 · doi:10.1016/j.actbio.2023.10.011
- Cong R, Deng C, Li P, et al. Dimeric copper peptide incorporated hydrogel for promoting diabetic wound healing. Nat Commun. 2025;16(1):5797. PubMed 40592840 · PMC12215000 · doi:10.1038/s41467-025-61141-1
- Huang ZJ, Huang RF, Jiao PP, et al. Copper peptide activated cascade catalysis for glucose regulation and hypoxia reversing in infected diabetic wound healing. Mater Today Bio. 2026;39:103396. PubMed 42404628 · PMC13330688 · doi:10.1016/j.mtbio.2026.103396
- Xie LH, Zhou XH, Wen WQ, et al. A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing. Carbohydr Polym. 2026;389:125628. PubMed 42586657 · doi:10.1016/j.carbpol.2026.125628
- Islam R, Bilal H, Wang X, et al. Tripeptides Ghk and GhkCu-modified silver nanoparticles for enhanced antibacterial and wound healing activities. Colloids Surf B Biointerfaces. 2024;236:113785. PubMed 38387323 · doi:10.1016/j.colsurfb.2024.113785
- Papaioannou A, Liakopoulou A, Papoulis D, et al. Effect of Peptides on the Synthesis, Properties and Wound Healing Capacity of Silver Nanoparticles. Pharmaceutics. 2023;15(10):2471. PubMed 37896231 · PMC10609782 · doi:10.3390/pharmaceutics15102471
- Chen H, Yang P, Xue P, et al. Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing. Biomater Res. 2025;29:0139. PubMed 39902373 · PMC11788471 · doi:10.34133/bmr.0139
- Jeon N, Kim L, Choi SG, et al. Self-Assembled Peptide-Gold Nanoparticle 1D Nanohybrids Functionalized with GHK Tripeptide for Enhanced Wound-Healing and Photothermal Therapy. ACS Appl Mater Interfaces. 2025;17(10):15080-15096. PubMed 40019920 · doi:10.1021/acsami.4c21924
- Yu X, Yang T, Bei Z, et al. Microenvironment-responsive injectable dynamic hydrogel for sequential antioxidant and tissue regeneration therapy of radiation-induced skin injury. Bioact Mater. 2026;63:778-794. PubMed 42058630 · PMC13123401 · doi:10.1016/j.bioactmat.2026.03.057
- Aguilar L, Garcia Gabastú E, Schaffner M, et al. Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability. ChemMedChem. 2026;21(8):e202501023. PubMed 42047624 · doi:10.1002/cmdc.202501023